Use of RDS MultiSense® in Post-ICU Patients in the COVID-19 Era
NCT ID: NCT04661423
Last Updated: 2025-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2021-09-02
2025-03-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of RDS MultiSense® in Desaturation Analysis in Healthy Volunteers
NCT05044585
Safety and Performance Study of the MultiSense® Ambulatory Telemonitoring System for Non-critical Patient Management
NCT05357729
REmote Data Acquisition After SURgery
NCT04480385
Non-Invasive Blood Pressure Monitoring in ICU Patients Using the DARE Device
NCT07052123
Remote Monitoring to Improve Physician Monitoring, Patient Satisfaction, and Predict Readmissions Following Surgery
NCT03800329
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to determine the quality of measurements of clinical signs provided by MultiSense® strip in comparison to measurements made with conventional medical devices in the hospital setting, in terms of accuracy, connectivity, generation of artifactual data and stability of data transmission. The study population includes 60 patients transferred to post-ICU units for a minimum of 5 days. Once in the post-ICU unit, the MultiSense® strip will be attached on patient's thorax. The monitoring will last between 5 to 7 days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Remote Automated Monitoring System
MultiSense® strip will be attached on patient's thorax. The monitoring will last between 5 and 7 days during the post-ICU hospitalization, at rest and during rehabilitation exercises.
Remote Automated Monitoring System
The patient will be monitored with conventional monitoring devices as well as the MultiSense patch.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remote Automated Monitoring System
The patient will be monitored with conventional monitoring devices as well as the MultiSense patch.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient previously cared in an ICU for severe COVID-19 pneumonia, COVID-related condition or similar neurological compromise necessitating post-ICU rehabilitation
* Negative respiratory SARS-CoV-2 (Severe Acute Respiratory Syndrome-Corona Virus-2) samples
* Patient admitted in a post-ICU rehabilitation unit with an expected length of stay \> 5 days
* Patient able to receive and understand information related to the study and give written informed consent.
OR If the patient is not capable, presence of a next of kin able to receive and understand information related to the study and give written informed consent for the patient
* Patient authorizing the treatment of their personal data collected during the study (box checked in the consent form)
* Patient affiliated to the French social security system.
Exclusion Criteria
* Patient with an implantable device such as a pacemaker
* Pregnant or lactating patient.
* Patient in exclusion period (determined by a previous or a current study).
* Patient under guardianship or trusteeship.
* Patient under the protection of justice.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rhythm Diagnostic Systems
INDUSTRY
IHU Strasbourg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julien POTTECHER, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Anesthesia, Critical Care & Perioperative Medicine, Hautepierre, Strasbourg, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anesthesia Department, Central Hospital
Nancy, , France
Anesthesia, Critical Care & Perioperative Medicine, Hautepierre
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pamuk K, Turan N. The effect of light on sleep quality and physiological parameters in patients in the intensive care unit. Appl Nurs Res. 2022 Aug;66:151607. doi: 10.1016/j.apnr.2022.151607. Epub 2022 Jun 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.